drugset / Trial / NCT01399827
Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to a) assess the efficacy of omega-3 fatty acids in the treatment of Deficient Emotional Self-Regulation (DESR) among stimulant treated Attention Deficit Hyperactivity Disorder (ADHD) adults, b) assess the side effect profile of omega-3 fatty acids in the treatment of DESR among stimulant treated ADHD adults, c) assess effects of omega-3 fatty acid supplementation on ADHD symptoms and associated features in stimulant treated ADHD adults, and d) predict value of fatty acids present in red blood cell membranes. This study will be a 12-week trial with adults 18-55 years of age with ADHD and symptoms of DESR.
Timeline
- Start
- 2012-02
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omega-3 fatty acids | Unknown | 1060 mg | — |
| Comparator | Amphetamine | Unknown | — | — |
| Comparator | Atomoxetine | Other / unclassified | — | — |
| Comparator | Dextroamphetamine | Small molecule | — | — |
| Comparator | Lisdexamfetamine Dimesylate | Small molecule | — | — |
| Comparator | Methylphenidate | Small molecule | — | — |
| Comparator | dexmethylphenidate | Unknown | — | — |
| Comparator | mixed amphetamine salts | Unknown | — | — |